Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Abstract Background Behçet’s disease is a chronic inflammatory multisystem disorder that is characterised by oral and/or genital ulcerations as well as intraocular inflammation. Recurrent retinal vasoocclusive episodes and macular involvement may lead to severe loss of visual acuity. Patients may ev...
Main Authors: | Tomona Hiyama, Yosuke Harada, Takehiko Doi, Yoshiaki Kiuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Pediatric Rheumatology Online Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12969-019-0333-6 |
Similar Items
-
Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
by: DA Al-Julandani, et al.
Published: (2023-03-01) -
Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
by: Takashi Ono, et al.
Published: (2020-06-01) -
Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
by: Biao Li, et al.
Published: (2023-07-01) -
The effectiveness of adalimumab treatment for non-infectious uveitis
by: Eiichi Hasegawa, et al.
Published: (2019-04-01) -
Profile of adalimumab and its potential in the treatment of uveitis
by: Balevic SJ, et al.
Published: (2016-09-01)